BSE filing, NSE: JSWDULUX. Summary written from the filing by ALFA Finder's alert engine.
JSW Dulux Ltd: key numbers
- Share price
- ₹276.50
- Market cap
- ₹12,663 Cr
- Revenue (annual)
- ₹3,599 Cr
- Net profit (annual)
- ₹1,974 Cr
- P/E (TTM)
- 6.5×Sector 42.1×
- Promoter holding
- 61.20%+0.00% QoQ
- FII holding
- 8.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from JSW Dulux Ltd
All →JSW Dulux Legal & Regulatory
JSW Dulux received a GST demand order for Rs. 42.04 Crore from Karnataka authorities. The company is evaluating the order for further submissions.
- Value
- ₹42.04 Cr
- From
- Karnataka GST Department
JSW Dulux Other Announcement
Routine quarterly shareholding pattern filing as per SEBI regulations, detailing promoter and public shareholding as of September 30, 2026.
JSW Dulux Board Meeting Date
JSW Dulux Limited has scheduled a board meeting on 4th November 2026 to consider and approve its standalone and consolidated financial results.
JSW Dulux Legal & Regulatory
JSW Dulux received a favorable MP GST appeal order annulling a Rs. 0.77 Crore demand. The company's prior tax liability is fully discharged.
- Value
- ₹0.77 Cr
JSW Dulux Legal & Regulatory
JSW Dulux received a GST show cause notice from the Punjab GST Department. The total disputed liability aggregates to Rs. 0.12 Crore.
- Value
- ₹0.12 Cr
- From
- Punjab GST Department
JSW Dulux Management Change
Mr. Rajiv Lochan Jha has resigned as General Counsel, Company Secretary, and Compliance Officer of JSW Dulux Limited. His last working day will be December 3, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.